CRON
CRON
NASDAQ · Pharmaceuticals

Cronos Group Inc

$2.39
-0.07 (-2.85%)
As of Mar 22, 10:09 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +1,150.2% upside
Low Target $20.40
Average Target $29.88
High Target $34.19
Current Price $2.39
Current
$2.39
Target
$29.88
$20.40 $29.88 avg $34.19
Scenario Analysis
Bear Case
$20.40
753.6%
Low target
Base Case
$29.88
+1,150.2%
Avg target
Bull Case
$34.19
+1,330.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$4.66
-48.7% from high
52-Week Low
$2.27
+5.3% from low
Target vs 52W High
$29.88
+541.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%